Unspecified juvenile rheumatoid arthritis
ICD-10 M08.0 is a billable code used to indicate a diagnosis of unspecified juvenile rheumatoid arthritis.
Unspecified juvenile rheumatoid arthritis (JRA) is a chronic inflammatory disorder primarily affecting children and adolescents, characterized by persistent arthritis in one or more joints. The pathophysiology involves an autoimmune response leading to synovial inflammation, joint damage, and potential systemic involvement. Clinically, JRA presents with joint swelling, pain, and stiffness, particularly in the morning or after periods of inactivity. Commonly affected joints include the knees, wrists, and ankles, but it can also involve the hips and shoulders. The condition may lead to growth disturbances and functional limitations due to joint deformities and reduced mobility. Early diagnosis and management are crucial to prevent long-term disability and improve quality of life.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage, functional assessments, and treatment plans detailing surgical or non-surgical interventions.
Common scenarios include joint injections, arthroscopy for joint debridement, and orthopedic interventions for joint deformities.
Documentation must specify which joints are affected and the severity of involvement, as well as any surgical history.
Rheumatologic documentation should include laboratory tests for inflammatory markers (e.g., ESR, CRP), disease activity scores, and patient-reported outcomes.
Scenarios often involve the initiation of disease-modifying antirheumatic drugs (DMARDs) and monitoring for side effects.
Consideration of systemic involvement, such as uveitis or growth retardation, is crucial for comprehensive care.
Functional assessments should evaluate mobility, strength, and endurance, along with rehabilitation goals and progress notes.
Rehabilitation scenarios may include physical therapy for joint mobility and strength training.
Documentation should address assistive devices used and any modifications made to daily activities.
Used for joint injections in managing JRA symptoms.
Document the joint involved, the procedure performed, and the patient's response.
Orthopedic and rheumatologic considerations for joint management.
Common symptoms include joint pain, swelling, stiffness, and potential systemic symptoms such as fever or rash. Early identification and management are crucial to prevent long-term complications.
